{"id":"https://openalex.org/W4391024400","doi":"https://doi.org/10.1016/j.xjidi.2024.100262","title":"Assessing Longitudinal Treatment Efficacies and Alterations in Molecular Markers Associated with Glutamatergic Signaling and Immune Checkpoint Inhibitors in a Spontaneous Melanoma Mouse Model","display_name":"Assessing Longitudinal Treatment Efficacies and Alterations in Molecular Markers Associated with Glutamatergic Signaling and Immune Checkpoint Inhibitors in a Spontaneous Melanoma Mouse Model","alternate_titles":[],"publication_year":2024,"publication_date":"2024-01-19","ids":{"openalex":"https://openalex.org/W4391024400","doi":"https://doi.org/10.1016/j.xjidi.2024.100262","pmid":"https://pubmed.ncbi.nlm.nih.gov/38445232","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10914525"},"language":"en","primary_location":{"id":"doi:10.1016/j.xjidi.2024.100262","doi":"https://doi.org/10.1016/j.xjidi.2024.100262","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xjidi.2024.100262","pdf_url":null,"source":{"id":"https://openalex.org/S4210189051","display_name":"JID Innovations","issn_l":"2667-0267","issn":["2667-0267"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JID Innovations","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4391024400"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.xjidi.2024.100262","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085949561","display_name":"Kevinn Eddy","orcid":"https://orcid.org/0000-0003-3531-6331","observed_orcids":["https://orcid.org/0000-0003-3531-6331"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevinn Eddy","raw_affiliation_strings":["Graduate Program in Cellular & Molecular Pharmacology, School of Graduate Studies, Rutgers University, Piscataway, New Jersey, USA","Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"],"raw_orcid":"https://orcid.org/0000-0003-3531-6331","affiliations":[{"raw_affiliation_string":"Graduate Program in Cellular & Molecular Pharmacology, School of Graduate Studies, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]},{"raw_affiliation_string":"Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023819670","display_name":"Kajal H. Gupta","orcid":"https://orcid.org/0000-0002-0665-1539","observed_orcids":["https://orcid.org/0000-0002-0665-1539"]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kajal Gupta","raw_affiliation_strings":["Division of Surgical Oncology, Department of Surgery, Rush University Medical Center, Chicago, Illinois, USA"],"raw_orcid":"https://orcid.org/0000-0002-0665-1539","affiliations":[{"raw_affiliation_string":"Division of Surgical Oncology, Department of Surgery, Rush University Medical Center, Chicago, Illinois, USA","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083850260","display_name":"Mohamad Naser Eddin","orcid":"https://orcid.org/0000-0001-8982-6025","observed_orcids":["https://orcid.org/0000-0001-8982-6025"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohamad Naser Eddin","raw_affiliation_strings":["Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"],"raw_orcid":"https://orcid.org/0000-0001-8982-6025","affiliations":[{"raw_affiliation_string":"Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027611723","display_name":"Christina Marinaro","orcid":"https://orcid.org/0000-0002-1979-0167","observed_orcids":["https://orcid.org/0000-0002-1979-0167"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina Marinaro","raw_affiliation_strings":["Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"],"raw_orcid":"https://orcid.org/0000-0002-1979-0167","affiliations":[{"raw_affiliation_string":"Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064221788","display_name":"Sanjana Putta","orcid":"https://orcid.org/0009-0007-1449-1524","observed_orcids":["https://orcid.org/0009-0007-1449-1524","https://orcid.org/0000-0002-5141-6474"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanjana Putta","raw_affiliation_strings":["Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"],"raw_orcid":"https://orcid.org/0000-0002-5141-6474","affiliations":[{"raw_affiliation_string":"Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077867906","display_name":"John Michael Sauer","orcid":"https://orcid.org/0009-0009-5083-2028","observed_orcids":["https://orcid.org/0009-0009-5083-2028"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Michael Sauer","raw_affiliation_strings":["Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"],"raw_orcid":"https://orcid.org/0009-0009-5083-2028","affiliations":[{"raw_affiliation_string":"Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071907889","display_name":"Anna L. Chaly","orcid":"https://orcid.org/0000-0002-6726-7063","observed_orcids":["https://orcid.org/0000-0002-6726-7063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Chaly","raw_affiliation_strings":["Fox Chase Therapeutics Discovery, Doylestown, Pennsylvania, USA"],"raw_orcid":"https://orcid.org/0000-0002-6726-7063","affiliations":[{"raw_affiliation_string":"Fox Chase Therapeutics Discovery, Doylestown, Pennsylvania, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036003228","display_name":"Katie B. Freeman","orcid":"https://orcid.org/0000-0003-4021-8808","observed_orcids":["https://orcid.org/0000-0003-4021-8808"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katie B. Freeman","raw_affiliation_strings":["Fox Chase Therapeutics Discovery, Doylestown, Pennsylvania, USA"],"raw_orcid":"https://orcid.org/0000-0003-4021-8808","affiliations":[{"raw_affiliation_string":"Fox Chase Therapeutics Discovery, Doylestown, Pennsylvania, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017508406","display_name":"Jeffrey C. Pelletier","orcid":"https://orcid.org/0000-0002-0397-0681","observed_orcids":["https://orcid.org/0000-0002-0397-0681"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey C. Pelletier","raw_affiliation_strings":["Fox Chase Therapeutics Discovery, Doylestown, Pennsylvania, USA"],"raw_orcid":"https://orcid.org/0000-0002-0397-0681","affiliations":[{"raw_affiliation_string":"Fox Chase Therapeutics Discovery, Doylestown, Pennsylvania, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045734565","display_name":"Anna Fateeva","orcid":"https://orcid.org/0000-0003-1801-434X","observed_orcids":["https://orcid.org/0000-0003-1801-434X"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Fateeva","raw_affiliation_strings":["Graduate Program in Cellular & Molecular Pharmacology, School of Graduate Studies, Rutgers University, Piscataway, New Jersey, USA","Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"],"raw_orcid":"https://orcid.org/0000-0003-1801-434X","affiliations":[{"raw_affiliation_string":"Graduate Program in Cellular & Molecular Pharmacology, School of Graduate Studies, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]},{"raw_affiliation_string":"Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035080887","display_name":"Philip Furmanski","orcid":"https://orcid.org/0009-0003-3931-3004","observed_orcids":["https://orcid.org/0009-0003-3931-3004"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]},{"id":"https://openalex.org/I4210109165","display_name":"Environmental and Occupational Health Sciences Institute","ror":"https://ror.org/01vta4r13","country_code":"US","type":"education","lineage":["https://openalex.org/I4210109165"]},{"id":"https://openalex.org/I4390039325","display_name":"Rutgers Cancer Institute","ror":"https://ror.org/0060x3y55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4390039325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip Furmanski","raw_affiliation_strings":["Environmental & Occupational Health Sciences Institute, Rutgers University, Piscataway, New Jersey, USA","Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA","Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"],"raw_orcid":"https://orcid.org/0009-0003-3931-3004","affiliations":[{"raw_affiliation_string":"Environmental & Occupational Health Sciences Institute, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142","https://openalex.org/I4210109165"]},{"raw_affiliation_string":"Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA","institution_ids":["https://openalex.org/I4390039325"]},{"raw_affiliation_string":"Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041474007","display_name":"Ann Willman Silk","orcid":"https://orcid.org/0000-0003-3877-3984","observed_orcids":["https://orcid.org/0000-0003-3877-3984"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann W. Silk","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA","Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0003-3877-3984","affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077715628","display_name":"Allen B. Reitz","orcid":"https://orcid.org/0000-0003-2780-4044","observed_orcids":["https://orcid.org/0000-0003-2780-4044"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allen B. Reitz","raw_affiliation_strings":["Fox Chase Therapeutics Discovery, Doylestown, Pennsylvania, USA"],"raw_orcid":"https://orcid.org/0000-0003-2780-4044","affiliations":[{"raw_affiliation_string":"Fox Chase Therapeutics Discovery, Doylestown, Pennsylvania, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075350327","display_name":"Andrew Zloza","orcid":"https://orcid.org/0000-0001-8844-6493","observed_orcids":["https://orcid.org/0000-0001-8844-6493"]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Zloza","raw_affiliation_strings":["Division of Hematology, Oncology, and Cell Therapy, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA"],"raw_orcid":"https://orcid.org/0000-0001-8844-6493","affiliations":[{"raw_affiliation_string":"Division of Hematology, Oncology, and Cell Therapy, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079683086","display_name":"Suzie Chen","orcid":"https://orcid.org/0000-0002-6384-5081","observed_orcids":["https://orcid.org/0000-0002-6384-5081"]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]},{"id":"https://openalex.org/I4210109165","display_name":"Environmental and Occupational Health Sciences Institute","ror":"https://ror.org/01vta4r13","country_code":"US","type":"education","lineage":["https://openalex.org/I4210109165"]},{"id":"https://openalex.org/I4390039325","display_name":"Rutgers Cancer Institute","ror":"https://ror.org/0060x3y55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4390039325"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Suzie Chen","raw_affiliation_strings":["Environmental & Occupational Health Sciences Institute, Rutgers University, Piscataway, New Jersey, USA","Graduate Program in Cellular & Molecular Pharmacology, School of Graduate Studies, Rutgers University, Piscataway, New Jersey, USA","Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA","Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA"],"raw_orcid":"https://orcid.org/0000-0002-6384-5081","affiliations":[{"raw_affiliation_string":"Environmental & Occupational Health Sciences Institute, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142","https://openalex.org/I4210109165"]},{"raw_affiliation_string":"Graduate Program in Cellular & Molecular Pharmacology, School of Graduate Studies, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]},{"raw_affiliation_string":"Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA","institution_ids":["https://openalex.org/I4390039325"]},{"raw_affiliation_string":"Susan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA","institution_ids":["https://openalex.org/I102322142"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5079683086"],"corresponding_institution_ids":["https://openalex.org/I102322142","https://openalex.org/I4210109165","https://openalex.org/I4390039325"],"apc_list":{"value":2000,"currency":"USD","value_usd":2000},"apc_paid":{"value":2000,"currency":"USD","value_usd":2000},"fwci":0.4314,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.58294203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"4","issue":"2","first_page":"100262","last_page":"100262"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8220000267028809},{"id":"https://openalex.org/keywords/glutamatergic-signaling","display_name":"glutamatergic signaling","score":0.7990000247955322},{"id":"https://openalex.org/keywords/glutamate-receptor-antagonists","display_name":"glutamate receptor antagonists","score":0.5889999866485596},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.9580000042915344},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.5950000286102295},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.9959999918937683},{"id":"https://openalex.org/keywords/sex-differences-in-treatment-response","display_name":"sex differences in treatment response","score":0.7590000033378601},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8040000200271606},{"id":"https://openalex.org/keywords/immune-cell-activation","display_name":"immune cell activation","score":0.5879999995231628},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.878000020980835},{"id":"https://openalex.org/keywords/slc7a11","display_name":"SLC7A11","score":0.8659999966621399},{"id":"https://openalex.org/keywords/gamma-h2ax","display_name":"\u03b3H2AX","score":0.9309999942779541},{"id":"https://openalex.org/keywords/glt-1","display_name":"GLT-1","score":0.996999979019165}],"concepts":[{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.7733360528945923},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7543318867683411},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5709458589553833},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5193368196487427},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4734456241130829},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.46241188049316406},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.45646655559539795},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4422132670879364},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.44042083621025085},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37892580032348633},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34955549240112305},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3029770255088806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2847144603729248},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.20749777555465698},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.14142191410064697},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.05543223023414612},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.xjidi.2024.100262","doi":"https://doi.org/10.1016/j.xjidi.2024.100262","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xjidi.2024.100262","pdf_url":null,"source":{"id":"https://openalex.org/S4210189051","display_name":"JID Innovations","issn_l":"2667-0267","issn":["2667-0267"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JID Innovations","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10914525","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10914525","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10914525/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JID Innov","raw_type":"Text"},{"id":"pmid:38445232","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38445232","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JID innovations : skin science from molecules to population health","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.xjidi.2024.100262","doi":"https://doi.org/10.1016/j.xjidi.2024.100262","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xjidi.2024.100262","pdf_url":null,"source":{"id":"https://openalex.org/S4210189051","display_name":"JID Innovations","issn_l":"2667-0267","issn":["2667-0267"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JID Innovations","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2137543862","display_name":"Riluzole Prodrugs for Melanoma and ALS","funder_award_id":"R44CA156781","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4532211710","display_name":null,"funder_award_id":"R44CA156781","funder_id":"https://openalex.org/F4320309030","funder_display_name":"Small Business Innovation Research"},{"id":"https://openalex.org/G5899763920","display_name":null,"funder_award_id":"IK6 BX006319","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G6049670457","display_name":null,"funder_award_id":"101BX003742","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G7272268267","display_name":null,"funder_award_id":"I01 BX003742","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G9000896750","display_name":"Summer Research Experience Programs (R25)","funder_award_id":"R25ES020721","funder_id":"https://openalex.org/F4320337361","funder_display_name":"National Institute of Environmental Health Sciences"}],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320309030","display_name":"Small Business Innovation Research","ror":"https://ror.org/015t55b95"},{"id":"https://openalex.org/F4320312581","display_name":"Rutgers, The State University of New Jersey","ror":null},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337361","display_name":"National Institute of Environmental Health Sciences","ror":"https://ror.org/00j4k1h63"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4391024400.pdf","grobid_xml":"https://content.openalex.org/works/W4391024400.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1530165143","https://openalex.org/W1987709528","https://openalex.org/W1992473608","https://openalex.org/W1995963726","https://openalex.org/W2013720557","https://openalex.org/W2014309354","https://openalex.org/W2016558185","https://openalex.org/W2017117125","https://openalex.org/W2019607817","https://openalex.org/W2025854374","https://openalex.org/W2039155569","https://openalex.org/W2039442454","https://openalex.org/W2054173142","https://openalex.org/W2062073691","https://openalex.org/W2066715779","https://openalex.org/W2082950409","https://openalex.org/W2089618836","https://openalex.org/W2096688677","https://openalex.org/W2104604857","https://openalex.org/W2114574923","https://openalex.org/W2138017475","https://openalex.org/W2144929127","https://openalex.org/W2146774792","https://openalex.org/W2523826139","https://openalex.org/W2779862163","https://openalex.org/W2783492856","https://openalex.org/W2790800342","https://openalex.org/W2792287598","https://openalex.org/W2901216244","https://openalex.org/W2920230491","https://openalex.org/W2936038815","https://openalex.org/W2944288745","https://openalex.org/W2947867419","https://openalex.org/W2988621811","https://openalex.org/W2996154729","https://openalex.org/W3011009916","https://openalex.org/W3015470279","https://openalex.org/W3031285754","https://openalex.org/W3049212237","https://openalex.org/W3086808029","https://openalex.org/W3090593425","https://openalex.org/W3109973033","https://openalex.org/W3118655301","https://openalex.org/W3191000096","https://openalex.org/W3192597389","https://openalex.org/W4200437644","https://openalex.org/W4283779285","https://openalex.org/W4285822031","https://openalex.org/W4295976968","https://openalex.org/W4361284919","https://openalex.org/W4390946922","https://openalex.org/W6809663171"],"related_works":["https://openalex.org/W4361284919","https://openalex.org/W3102783889","https://openalex.org/W2134091727","https://openalex.org/W3193865575","https://openalex.org/W3154074238","https://openalex.org/W2954682242","https://openalex.org/W4242078802","https://openalex.org/W2888808152","https://openalex.org/W2969843369","https://openalex.org/W4404064510"],"abstract_inverted_index":{"Previous":[0],"work":[1],"done":[2],"by":[3],"our":[4],"laboratory":[5],"described":[6],"the":[7,52,55,120,123,197,227,235,245,252],"use":[8],"of":[9,24,54,101,122,175,188,191,200,202,204,216,229,237,247,249,254],"an":[10,115],"immunocompetent":[11],"spontaneous":[12],"melanoma-prone":[13],"mouse":[14,125],"model,":[15],"TGS":[16,124],"(TG-3/SKH-1),":[17],"to":[18,64,114,127],"evaluate":[19],"treatment":[20,106,152,182,230],"outcomes":[21],"using":[22,154],"inhibitors":[23,203],"glutamatergic":[25,56,205],"signaling":[26,57,206],"and":[27,94,110,148,161,172,207,221,262],"immune":[28,158,162,169,208],"checkpoint":[29,209],"for":[30,112,157],"18":[31,108],"weeks.":[32],"We":[33],"showed":[34,210],"a":[35,40,97,129,135,189,255],"significant":[36],"therapeutic":[37,132,258],"efficacy":[38],"with":[39,91,226,244],"notable":[41],"sex-biased":[42],"response":[43],"in":[44,69,72,82,87,134,146,181,184,213,240,260],"male":[45,77,88],"mice.":[46,78,186],"In":[47],"this":[48],"follow-up":[49],"18-week":[50],"study,":[51],"dose":[53],"inhibitor":[58],"was":[59,85,103],"increased":[60],"(from":[61],"1.7":[62],"mg/kg":[63],"25":[65],"mg/kg),":[66],"which":[67],"resulted":[68],"improved":[70],"responses":[71,183],"female":[73],"mice":[74,89,102],"but":[75],"not":[76],"The":[79,165],"greatest":[80],"reduction":[81],"tumor":[83,149],"progression":[84],"observed":[86],"treated":[90],"single-agent":[92],"troriluzole":[93],"anti-PD-1.":[95],"Furthermore,":[96],"randomly":[98],"selected":[99],"group":[100,190],"removed":[104],"from":[105],"after":[107],"weeks":[109,118],"maintained":[111],"up":[113],"additional":[116],"48":[117],"demonstrating":[119],"utility":[121],"model":[126],"perform":[128],"\u22651-year":[130],"preclinical":[131,257],"study":[133,259],"physiologically":[136],"relevant":[137],"tumor-host":[138],"environment.":[139],"Digital":[140],"spatial":[141,261],"imaging":[142],"analyses":[143],"were":[144],"performed":[145],"tumors":[147],"microenvironments":[150],"across":[151],"modalities":[153],"antibody":[155],"panels":[156],"cell":[159,163,170],"types":[160],"activation.":[164],"results":[166,233],"suggest":[167,234],"that":[168,211],"populations":[171],"cytotoxic":[173],"activities":[174],"T":[176],"cells":[177],"play":[178],"critical":[179],"roles":[180],"these":[185],"Examination":[187],"molecular":[192,241],"protein":[193],"markers":[194,242],"based":[195],"on":[196],"proposed":[198],"mechanisms":[199],"action":[201,248],"alterations":[212],"expression":[214],"levels":[215],"xCT,":[217],"\u03b3-H2AX,":[218],"EAAT2,":[219],"PD-L1,":[220],"PD-1":[222],"are":[223],"likely":[224],"associated":[225,243],"loss":[228],"responses.":[231],"These":[232],"importance":[236],"tracking":[238],"changes":[239],"mechanism":[246],"therapeutics":[250],"over":[251],"course":[253],"longitudinal":[256],"temporal":[263],"manners.":[264]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4391024400","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2024-01-20T00:00:00"}
